Nucor earnings beat by $0.08, revenue fell short of estimates
MINNEAPOLIS—Kristie Burns, the Senior Vice President of Marketing and Clinical Affairs at Tactile Systems Technology Inc . (NASDAQ:TCMD), a medical technology company with a market capitalization of $336 million, recently sold shares of the company’s common stock. According to InvestingPro data, TCMD maintains a "GREAT" financial health score, with strong balance sheet indicators showing more cash than debt. According to a filing with the Securities and Exchange Commission, Burns sold a total of 6,468 shares on February 25, 2025. The shares were sold at a weighted average price of $14.4032, totaling approximately $93,159.
The transaction was conducted to cover taxes associated with the settlement of stock units. Following this sale, Burns retains ownership of 77,540 shares of Tactile Systems Technology. The sale prices for the shares ranged from $14.40 to $14.41 per share.
In other recent news, Tactile Systems Technology has reported its fourth-quarter financial results for 2024, surpassing expectations with earnings per share (EPS) of $0.40, compared to the forecast of $0.31. The company achieved a revenue of $85.6 million, slightly above the anticipated $85.41 million, marking a 10.2% increase year-over-year. Despite these positive results, B. Riley analysts downgraded Tactile Systems from Buy to Neutral, adjusting the price target to $18, citing concerns over slowing earnings growth and ongoing legal challenges. The company’s guidance for fiscal year 2025 projects revenue between $316 million and $322 million, with adjusted EBITDA expected to range from $35 million to $37 million, which did not meet the consensus estimate of $45.2 million. Tactile Systems is focusing on expanding its lymphedema and airway clearance product lines and improving patient access to care. Additionally, the company highlighted new product launches and innovations during its earnings call. The analysts at B. Riley expressed concerns regarding the company’s market share for its airway clearance products in 2025. Despite the challenges, Tactile Systems remains committed to market development through education and strategic investments.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.